SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,060.14 |
| Enterprise Value ($M) | 960.00 |
| Book Value ($M) | 245.91 |
| Book Value / Share | 5.25 |
| Price / Book | 4.31 |
| NCAV ($M) | 240.19 |
| NCAV / Share | 5.13 |
| Price / NCAV | 4.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.28 |
| Current Ratio | 10.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 266.15 |
| Assets | 271.87 |
| Liabilities | 25.96 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -82.23 |
| Net Income | -71.58 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -61.27 |
| Cash from Investing | -148.41 |
| Cash from Financing | 234.29 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | 5AM Ventures VI, L.P. | 6.10 | -26.07 | |
| 13D/A | Orbimed Advisors Llc | 19.20 | 0.02 | |
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 7.20 | 33.46 | |
| 13G/A | Fairmount Funds Management LLC | 5.20 | 0.32 | |
| 13G/A | Pfizer Inc | 0.95 | ||
| 13G/A | Commodore Capital Lp | 7.00 | 39.37 | |
| 13G/A | Citadel Advisors Llc | 5.80 | ||
| 13G/A | Fmr Llc | 14.32 | 33.55 | |
| 13G/A | BML Investment Partners, L.P. | 0.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 78,765 | 76,314 | 103.21 | |
| 193,438 | 482,543 | 40.09 | |
| 45,317 | 62,451 | 72.56 | |
| 40,323 | 74,472 | 54.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DVAX – Dynavax Technologies Corporation | EDIT – Editas Medicine, Inc. |
| ELEV – Elevation Oncology, Inc. | ENTA – Enanta Pharmaceuticals, Inc. |
| ERAS – Erasca, Inc. |
Financial data and stock pages provided by
Fintel.io